In support of our mutual commitment to our members’ well-being during this public health emergency, if you have any patients who currently receive Remicade or Privigen infusions in an office or clinic, please consider moving them to a home infusion provider. We are starting with these medications, given the chronic nature and high prevalence of use.
Because these patients are at a considerably greater risk of complications from COVID-19 infection, those who can effectively and safely receive these infusions at home should do so to circumvent the exposure risk presented by traveling to an infusion center. Harvard Pilgrim is happy to assist you with the temporary transfer of prior authorization to a home service provider, which may be reversed when it’s safe to relax social distancing efforts.
While you may select any in-network home infusion agency you would like to transfer your patients to, Harvard Pilgrim has identified three contracted home infusion providers who currently have capacity:
- CORAM/CVS: 866-899-1661
- New England Life Care: 1-800-290-6558 x4195
- Option Care Health: 1-800-624-4584
For assistance in facilitating the temporary transfer, please contact Harvard Pilgrim’s Care Management Department at 866-750-2068.
For any questions you may have about Harvard Pilgrim’s response to the COVID-19 pandemic, please refer to the resources offered on our provider website.